Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Calithera Biosciences stock remained flat at $0.02 during trading on Friday. The company had a trading volume of 15 shares, compared to its average volume of 3,445. Calithera Biosciences has a 52-week low of $0.02 and a 52-week high of $0.50. The stock has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.03.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.